• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孤立性肌张力障碍基因的基因型-表型关系:MDSGene 系统评价。

Genotype-Phenotype Relations for Isolated Dystonia Genes: MDSGene Systematic Review.

机构信息

Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.

Department of Neurology, University of Lübeck, Lübeck, Germany.

出版信息

Mov Disord. 2021 May;36(5):1086-1103. doi: 10.1002/mds.28485. Epub 2021 Jan 27.

DOI:10.1002/mds.28485
PMID:33502045
Abstract

This comprehensive MDSGene review is devoted to 7 genes - TOR1A, THAP1, GNAL, ANO3, PRKRA, KMT2B, and HPCA - mutations in which may cause isolated dystonia. It followed MDSGene's standardized data extraction protocol and screened a total of ~1200 citations. Phenotypic and genotypic data on ~1200 patients with 254 different mutations were curated and analyzed. There were differences regarding age at onset, site of onset, and distribution of symptoms across mutation carriers in all 7 genes. Although carriers of TOR1A, THAP1, PRKRA, KMT2B, or HPCA mutations mostly showed childhood and adolescent onset, patients with GNAL and ANO3 mutations often developed first symptoms in adulthood. GNAL and KMT2B mutation carriers frequently have 1 predominant site of onset, that is, the neck (GNAL) or the lower limbs (KMT2B), whereas site of onset in DYT-TOR1A, DYT-THAP1, DYT-ANO3, DYT-PRKRA, and DYT-HPCA was broader. However, in most DYT-THAP1 and DYT-ANO3 patients, dystonia first manifested in the upper half of the body (upper limb, neck, and craniofacial/laryngeal), whereas onset in DYT-TOR1A, DYT-PRKRA and DYT-HPCA was frequently observed in an extremity, including both upper and lower ones. For ANO3, a segmental/multifocal distribution was typical, whereas TOR1A, PRKRA, KMT2B, and HPCA mutation carriers commonly developed generalized dystonia. THAP1 mutation carriers presented with focal, segmental/multifocal, or generalized dystonia in almost equal proportions. GNAL mutation carriers rarely showed generalization. This review provides a comprehensive overview of the current knowledge of hereditary isolated dystonia. The data are also available in an online database (http://www.mdsgene.org), which additionally offers descriptive summary statistics. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

摘要

这篇全面的 MDSGene 综述专注于 7 个基因——TOR1A、THAP1、GNAL、ANO3、PRKRA、KMT2B 和 HPCA——这些基因突变可能导致孤立性肌张力障碍。它遵循 MDSGene 的标准化数据提取协议,共筛选了约 1200 篇参考文献。对约 1200 名患有 254 种不同突变的患者的表型和基因型数据进行了整理和分析。在所有 7 个基因中,突变携带者的发病年龄、发病部位和症状分布存在差异。虽然 TOR1A、THAP1、PRKRA、KMT2B 或 HPCA 突变携带者大多表现为儿童和青少年发病,但 GNAL 和 ANO3 突变携带者常于成年后出现首发症状。GNAL 和 KMT2B 突变携带者常以 1 个主要发病部位为首发,即颈部(GNAL)或下肢(KMT2B),而 DYT-TOR1A、DYT-THAP1、DYT-ANO3、DYT-PRKRA 和 DYT-HPCA 的发病部位更为广泛。然而,在大多数 DYT-THAP1 和 DYT-ANO3 患者中,肌张力障碍首先表现为上半身(上肢、颈部和颅面部/喉部),而 DYT-TOR1A、DYT-PRKRA 和 DYT-HPCA 的发病部位常发生在四肢,包括上下肢。ANO3 患者常表现为节段性/多灶性分布,而 TOR1A、PRKRA、KMT2B 和 HPCA 突变携带者常表现为全身性肌张力障碍。THAP1 突变携带者的局灶性、节段性/多灶性或全身性肌张力障碍的发病比例几乎相等。GNAL 突变携带者很少出现全身性表现。本综述全面概述了遗传性孤立性肌张力障碍的现有知识。这些数据也可在在线数据库(http://www.mdsgene.org)中获得,该数据库还提供描述性汇总统计信息。© 2021 作者。运动障碍由 Wiley 期刊出版公司代表国际帕金森病和运动障碍学会出版。

相似文献

1
Genotype-Phenotype Relations for Isolated Dystonia Genes: MDSGene Systematic Review.孤立性肌张力障碍基因的基因型-表型关系:MDSGene 系统评价。
Mov Disord. 2021 May;36(5):1086-1103. doi: 10.1002/mds.28485. Epub 2021 Jan 27.
2
Tremor in Primary Monogenic Dystonia.原发性单基因运动障碍中的震颤。
Curr Neurol Neurosci Rep. 2021 Jul 15;21(9):48. doi: 10.1007/s11910-021-01135-w.
3
Relationship of Genotype, Phenotype, and Treatment in Dopa-Responsive Dystonia: MDSGene Review.多巴反应性肌张力障碍的基因型、表型与治疗的关系:MDS基因综述
Mov Disord. 2022 Feb;37(2):237-252. doi: 10.1002/mds.28874. Epub 2021 Dec 15.
4
Mutational spectrum of GNAL, THAP1 and TOR1A genes in isolated dystonia: study in a population from Spain and systematic literature review.GNAL、THAP1 和 TOR1A 基因在孤立性肌张力障碍中的突变谱:来自西班牙人群的研究和系统文献复习。
Eur J Neurol. 2021 Apr;28(4):1188-1197. doi: 10.1111/ene.14638. Epub 2020 Dec 6.
5
Isolated dystonia: clinical and genetic updates.孤立性肌张力障碍:临床和遗传学更新。
J Neural Transm (Vienna). 2021 Apr;128(4):405-416. doi: 10.1007/s00702-020-02268-x. Epub 2020 Nov 27.
6
Large-Scale Screening: Phenotypic and Mutational Spectrum in Isolated and Combined Dystonia Genes.大规模筛查:孤立性和联合性肌张力障碍基因的表型和突变谱。
Mov Disord. 2024 Mar;39(3):526-538. doi: 10.1002/mds.29693. Epub 2024 Jan 12.
7
Heterogeneity in primary dystonia: lessons from THAP1, GNAL, and TOR1A in Amish-Mennonites.原发性肌张力障碍的异质性:阿米什-门诺派中THAP1、GNAL和TOR1A的启示
Mov Disord. 2014 May;29(6):812-8. doi: 10.1002/mds.25818. Epub 2014 Feb 5.
8
Trihexyphenidyl for dystonia in cerebral palsy.用于治疗脑瘫肌张力障碍的苯海索
Cochrane Database Syst Rev. 2018 May 15;5(5):CD012430. doi: 10.1002/14651858.CD012430.pub2.
9
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
10
Botulinum toxin type B for cervical dystonia.用于治疗颈部肌张力障碍的B型肉毒毒素
Cochrane Database Syst Rev. 2005 Jan 25(1):CD004315. doi: 10.1002/14651858.CD004315.pub2.

引用本文的文献

1
Generalized dystonia unraveled: Molecular mechanisms, diagnostic strategies, and treatment paradigms.全面解析全身性肌张力障碍:分子机制、诊断策略及治疗模式
Neurol Sci. 2025 Aug 22. doi: 10.1007/s10072-025-08404-3.
2
Pediatric Genetic Dystonias: Current Diagnostic Approaches and Treatment Options.小儿遗传性肌张力障碍:当前的诊断方法与治疗选择
Life (Basel). 2025 Jun 20;15(7):992. doi: 10.3390/life15070992.
3
Rare but Relevant: Assessing Variants in Dystonia-linked Genes in Parkinson's Disease.罕见但相关:评估帕金森病中肌张力障碍相关基因的变异
medRxiv. 2025 Jul 11:2025.07.10.25330831. doi: 10.1101/2025.07.10.25330831.
4
Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large-Scale Exome Sequencing.肌张力障碍的遗传多样性与扩展表型:来自大规模外显子组测序的见解
Ann Clin Transl Neurol. 2025 Jun 18. doi: 10.1002/acn3.70100.
5
Genotype-Phenotype Relations for the Dystonia-Parkinsonism Genes , , , , and : MDSGene Systematic Review.肌张力障碍-帕金森综合征相关基因、、、和的基因型-表型关系:MDS基因系统评价
Int J Mol Sci. 2025 Apr 25;26(9):4074. doi: 10.3390/ijms26094074.
6
Long-Read Sequencing: The Third Generation of Diagnostic Testing for Dystonia.长读长测序:肌张力障碍的第三代诊断检测方法
Mov Disord. 2025 Jun;40(6):1009-1019. doi: 10.1002/mds.30208. Epub 2025 Apr 23.
7
Retrospective chart review of inherited and idiopathic dystonia.遗传性和特发性肌张力障碍的回顾性病历审查。
Front Genet. 2025 Mar 11;16:1504744. doi: 10.3389/fgene.2025.1504744. eCollection 2025.
8
Loss-of-function mutations in the dystonia gene THAP1 impair proteasome function by inhibiting PSMB5 expression.肌张力障碍基因THAP1中的功能丧失突变通过抑制PSMB5的表达损害蛋白酶体功能。
Nat Commun. 2025 Feb 10;16(1):1511. doi: 10.1038/s41467-025-56782-1.
9
Deletion of the THAP1 Gene Is Responsible for Typical DYT-THAP1.THAP1基因的缺失是典型DYT-THAP1型肌张力障碍的病因。
Mov Disord Clin Pract. 2025 May;12(5):691-693. doi: 10.1002/mdc3.14350. Epub 2025 Jan 30.
10
Genetic Diversity and Expanded Phenotypes in Dystonia: Insights from Large-Scale Exome Sequencing.肌张力障碍的遗传多样性与扩展表型:来自大规模外显子组测序的见解
medRxiv. 2024 Dec 5:2024.12.02.24316741. doi: 10.1101/2024.12.02.24316741.